2016-12-10T00-22-31Z
Source: Indo American Journal of Pharmaceutical Research
Dr. Kinna Shah, Dr. B.M Patel.
Aim: To evaluate the effect of ketofol on haemodynamic response and recovery parameters and to compare it with Propofol in direct laryngoscopic examination /biopsy (DLBX). Method: Three hundred fifteen patients posted for DLB were allocated in this prospective double blind study. Patients were randomly assigned to either Group KP (Ketamine 50 mg +Propofol 100mg in 10 cc) or Group P (100 mg in 10 cc).Inj. Succinylcholine 1mg/kg given in all patients. Pulse, BP and Spo2 were noted at 0, 1, 3, 5, 7 minutes and after every 15 minutes interval up to discharge. Total volume of drug used and Ramsay sedation scale in each procedure was noted. Results: Time to eye opening was earlier in Group KP (10.56+/-4.22v/s 15.82+/-5.66 P value
http://ift.tt/2hwrWbV
Σάββατο 10 Δεκεμβρίου 2016
COMPARISON OF A SINGLE SYRINGE MIXTURE OF KETAMINE AND PROPOFOL (KETOFOL) AND PROPOFOL AS AN ANESTHETIC AGENT IN DIRECT LARYNGEAL BIOPSY PROCEDURE
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Excerpt from Common Culture: Reading and Writing About American Popular Culture. Ed. Michael Petracca, Madeleine Sorapure. Upper Saddle Rive...
-
Thesis Statement Creator: Directions: This web page explains the different parts to a thesis statement and helps you create your own. You ca...
-
Robert Schumann regnes som en av de store romantiske komponistene, særlig anerkjent er hans klaver- og kammermusikk. Han startet på utdanni...
-
Effect of titanium oxide and zirconium oxide nanoparticle incorporation on the flexural strength of heat-activated polymethyl methacrylate d...
-
Abstract Objectives Patients undergoing osteoporosis treatment benefit greatly from early detection. We previously developed a computer-...
-
Publication date: Available online 20 March 2018 Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology Author(s): Tobia...
-
Oncolytic viruses show specific targeting and killing of tumor cells and therefore provide attractive assets for cancer immunotherapy. In pa...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου